0001062993-15-003150.txt : 20150601 0001062993-15-003150.hdr.sgml : 20150601 20150601115639 ACCESSION NUMBER: 0001062993-15-003150 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150529 FILED AS OF DATE: 20150601 DATE AS OF CHANGE: 20150601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gitman Paul CENTRAL INDEX KEY: 0001375378 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 15902055 MAIL ADDRESS: STREET 1: 167 EXECUTIVE DRIVE CITY: MANHASSET HILLS STATE: NY ZIP: 11040 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2015-05-29 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001375378 Gitman Paul C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 WILBUR STREET LYNBROOK NY 11563 1 0 0 0 Common Stock, $0.001 par value 2015-05-29 4 S 0 11000 46.75 D 55825 D Common Stock, $0.001 par value 2015-05-29 4 S 0 4000 46.79 D 51825 D The transactions reported in this Form 4 were effected outside of the Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2014 in an open trading window. /s/ Paul Gitman by Carl A. Valenstein, attorney-in-fact 2015-06-01